{"filing":{"accession_number":"0000049071-26-000045","cik":"0000049071","ticker":"HUM","company_name":"HUMANA INC","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"hum-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907126000045/hum-20260729.htm"},"events":[{"id":21322,"run_id":19227,"accession_number":"0000049071-26-000045","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Humana reported second quarter 2026 financial results with GAAP EPS of $5.73 and Adjusted EPS of $7.61, along with year-to-date results and revised full-year 2026 guidance. The earnings release includes detailed financial tables, segment performance metrics, and forward guidance.","company_name":"HUMANA INC","ticker":"HUM","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":20940,"accession_number":"0000049071-26-000045","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Humana's second quarter 2026 financial results. The filing reports 2Q26 GAAP EPS of $5.73 and Adjusted EPS of $7.61, along with year-to-date results and full-year 2026 guidance revisions. The document explicitly states \"Humana Reports Second Quarter 2026 Financial Results\" and includes detailed financial tables, segment performance metrics, and forward guidance, which are hallmarks of a quarterly earnings disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T10:20:41.278763+00:00","company_name":"","ticker":null,"filing_date":""},{"id":20941,"accession_number":"0000049071-26-000045","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Humana disclosed quarterly financial results for Q2 2026 via press release and detailed earnings release, reporting 2Q26 GAAP EPS of $5.73 and Adjusted EPS of $7.61, along with full-year 2026 guidance revisions. The Item 7.01 disclosure explicitly references the attached earnings releases (Exhibits 99.1 and 99.2) and management's prepared remarks on financial results and future earnings expectations, which is the hallmark of an earnings_release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T10:20:41.278763+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20940,"accession_number":"0000049071-26-000045","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Humana's second quarter 2026 financial results. The filing reports 2Q26 GAAP EPS of $5.73 and Adjusted EPS of $7.61, along with year-to-date results and full-year 2026 guidance revisions. The document explicitly states \"Humana Reports Second Quarter 2026 Financial Results\" and includes detailed financial tables, segment performance metrics, and forward guidance, which are hallmarks of a quarterly earnings disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T10:20:41.278763+00:00","company_name":"HUMANA INC","ticker":"HUM","filing_date":"2026-07-29"},{"id":20941,"accession_number":"0000049071-26-000045","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Humana disclosed quarterly financial results for Q2 2026 via press release and detailed earnings release, reporting 2Q26 GAAP EPS of $5.73 and Adjusted EPS of $7.61, along with full-year 2026 guidance revisions. The Item 7.01 disclosure explicitly references the attached earnings releases (Exhibits 99.1 and 99.2) and management's prepared remarks on financial results and future earnings expectations, which is the hallmark of an earnings_release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T10:20:41.278763+00:00","company_name":"HUMANA INC","ticker":"HUM","filing_date":"2026-07-29"}]}